‪Professor Kyriakos E. Kypreos‬

Cited by

	All	Since 2019
Citations	3402	1426
h-index	40	22
i10-index	68	44

300

150

225

1999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202412 6 18 20 28 54 53 31 66 73 63 106 174 144 156 193 176 189 209 168 230 213 273 244 281 185

Public access

View all

14 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Eleni KaraviaUniversity of Patras, School of Health Sciences, Department of Medicine, Pharmacology laboratoryVerified email at upatras.gr
Evangelia ZvintzouUniversity of PatrasVerified email at upatras.gr
Xepapadaki EvaUniversity of PatrasVerified email at upatras.gr
Dionysios J. Papachristou MD, PhDProfessor, Univ. of Patras, School of Medicine, Patras, Greece; Adj. Professor, Univ. of PittsburghVerified email at med.upatras.gr
Ko Willems van DijkLeiden University Medical CenterVerified email at lumc.nl
Louis HavekesTNO Metabolic Health Research and Prof. Leiden University Medical Center, Leiden, the NetherlandsVerified email at tno.nl
Angeliki ChroniNational Center for Scientific Research DemokritosVerified email at bio.demokritos.gr
Harry C. BlairProfessor of Pathology, University of PittsburghVerified email at pitt.edu
Iordanis KaragiannidisAssociate Professor of Medicine, UCLAVerified email at mednet.ucla.edu
George SakellaropoulosSchool of Medicine, University of PatrasVerified email at med.upatras.gr
Patrick RensenProfessor of Endocrinology, Leiden University Medical Center, Leiden, The NetherlandsVerified email at lumc.nl
Shlomo SassonProfessor of PhramacologyVerified email at mail.huji.ac.il
Konstantinos DrosatosUniversity of Cincinnati College of MedicineVerified email at uc.edu
Giuseppe MaulucciNeuroscience dept, Biophysics section Università Cattolica del Sacro CuoreVerified email at unicatt.it
Loukianos RallidisNational and Kapodistrian University of AthensVerified email at med.uoa.gr
CARLA FERRERIConsiglio Nazionale delle RicercheVerified email at isof.cnr.it
CHRYSSOSTOMOS CHATGILIALOGLUConsiglio Nazionale delle RicercheVerified email at isof.cnr.it
STEPHEN FARMERProfessor of BiochemistryVerified email at bu.edu
Kassiani LiopetaDepartment of Microbiology, School of Medicine, University of Patras, GreeceVerified email at upatras.gr
Despina Sanoudou4th Department of Internal Medicine, Medical School, National and Kapodistrian University of AthensVerified email at med.uoa.gr

Professor Kyriakos E. Kypreos

University of Patras School of Health Sciences, Department of Medicine, Pharmacology laboratory

Verified email at upatras.gr - Homepage

Metabolic syndrome Lipid and lipoprotein metabolism Dyslipidemia Cardiovascular health White adipose tissue (wat) and Brown


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
HDL biogenesis and functions: role of HDL quality and quantity in atherosclerosis EM Tsompanidi, MS Brinkmeier, EH Fotiadou, SM Giakoumi, KE Kypreos Atherosclerosis 208 (1), 3-9, 2010	218	2010
Fatty acid-related modulations of membrane fluidity in cells: detection and implications G Maulucci, O Cohen, B Daniel, A Sansone, PI Petropoulou, S Filou, ... Free radical research 50 (sup1), S40-S50, 2016	155	2016
Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT KE Kypreos, VI Zannis Biochemical Journal 403 (2), 359-367, 2007	120	2007
Androgen deficiency and atherosclerosis: The lipid link AM Traish, R Abdou, KE Kypreos Vascular pharmacology 51 (5-6), 303-313, 2009	114	2009
Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet IE Triantaphyllidou, E Kalyvioti, E Karavia, I Lilis, KE Kypreos, ... Osteoarthritis and cartilage 21 (2), 322-330, 2013	109	2013
Testosterone and cardiovascular disease: an old idea with modern clinical implications AM Traish, KE Kypreos Atherosclerosis 214 (2), 244-248, 2011	99	2011
Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer VI Zannis, A Chroni, KE Kypreos, HY Kan, TB Cesar, EE Zanni, ... Current opinion in lipidology 15 (2), 151-166, 2004	93	2004
Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice I Karagiannides, R Abdou, A Tzortzopoulou, PJ Voshol, KE Kypreos The FEBS journal 275 (19), 4796-4809, 2008	91	2008
Domains of Apolipoprotein E Contributing to Triglyceride and Cholesterol Homeostasis in Vivo: CARBOXYL-TERMINAL REGION 203–299 PROMOTES HEPATIC VERY LOW DENSITY LIPOPROTEIN … KE Kypreos, KW van Dijk, A van der Zee, LM Havekes, VI Zannis Journal of Biological Chemistry 276 (23), 19778-19786, 2001	78	2001
Increased CUG triplet repeat-binding protein-1 predisposes to impaired adipogenesis with aging I Karagiannides, T Thomou, T Tchkonia, T Pirtskhalava, KE Kypreos, ... Journal of Biological Chemistry 281 (32), 23025-23033, 2006	77	2006
Lipoproteins and atherogenesis VI Zannis, KE Kypreos, A Chroni, D Kardassis, EE Zanni Molecular mechanisms of atherosclerosis 8, 111-174, 2004	74	2004
High-density lipoprotein (HDL) metabolism and bone mass NI Papachristou, HC Blair, KE Kypreos, DJ Papachristou The Journal of endocrinology 233 (2), R95, 2017	70	2017
Apolipoprotein AI modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice EA Karavia, DJ Papachristou, K Liopeta, IE Triantaphyllidou, ... Molecular Medicine 18, 901-912, 2012	69	2012
Mechanisms of obesity and related pathologies: role of apolipoprotein E in the development of obesity KE Kypreos, I Karagiannides, EH Fotiadou, EA Karavia, MS Brinkmeier, ... The FEBS Journal 276 (20), 5720-5728, 2009	69	2009
ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia KE Kypreos Biochemistry 47 (39), 10491-10502, 2008	64	2008
Domains of apoE required for binding to apoE receptor 2 and to phospholipids: implications for the functions of apoE in the brain X Li, K Kypreos, EE Zanni, V Zannis Biochemistry 42 (35), 10406-10417, 2003	64	2003
SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux A Chroni, TJF Nieland, KE Kypreos, M Krieger, VI Zannis Biochemistry 44 (39), 13132-13143, 2005	61	2005
Regulation of endothelial nitric oxide synthase and high-density lipoprotein quality by estradiol in cardiovascular pathology KE Kypreos, S Zafirovic, PI Petropoulou, P Bjelogrlic, I Resanovic, ... Journal of cardiovascular Pharmacology and Therapeutics 19 (3), 256-268, 2014	60	2014
Distinct roles of apolipoproteins A1 and E in the modulation of high-density lipoprotein composition and function S Filou, M Lhomme, EA Karavia, C Kalogeropoulou, V Theodoropoulos, ... Biochemistry 55 (27), 3752-3762, 2016	59	2016
Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein AI (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce … A Chroni, HY Kan, KE Kypreos, IN Gorshkova, A Shkodrani, VI Zannis Biochemistry 43 (32), 10442-10457, 2004	58	2004

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors